Xcelerate Inc.
XCRT • Medical - Care Facilities
$0.03
▲ +0.00 (+0.06%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$10.86M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 89.9%Weak liquidity · 0.15Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.03
Change0.06%
Shares Out434.45M
Market Cap$10.86M
Enterprise Value$12.38M
52W Range0.01 - 0.02
Beta1.99
P/E-9.64
P/S-16.80
P/B-5.25
P/FCF-25.48
EV/Sales-19.15
Price$0.03
Change0.06%
Shares Out434.45M
Market Cap$10.86M
Enterprise Value$12.38M
52W Range0.01 - 0.02
Beta1.99
P/E-9.64
P/S-16.80
P/B-5.25
P/FCF-25.48
EV/Sales-19.15
EV/EBITDA-106.88
EV/FCF-29.04
Earnings Yield-10.37%
FCF Yield-3.93%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.91
Current Ratio0.15
Quick Ratio0.15
Volume5.10K
Avg Volume130.86K
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Positive revenue growth · 89.9%Weak liquidity · 0.15Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.